KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Intuitive Surgical (ISRG) over the last 16 years, with Q4 2025 value amounting to $13.1 million.

  • Intuitive Surgical's Gains from Investment Securities rose 480.0% to $13.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $419.1 million, marking a year-over-year increase of 5522.22%. This contributed to the annual value of $419.1 million for FY2025, which is 5522.22% up from last year.
  • Latest data reveals that Intuitive Surgical reported Gains from Investment Securities of $13.1 million as of Q4 2025, which was up 480.0% from $19.7 million recorded in Q3 2025.
  • Intuitive Surgical's 5-year Gains from Investment Securities high stood at $370.1 million for Q1 2025, and its period low was $6.8 million during Q2 2022.
  • Over the past 5 years, Intuitive Surgical's median Gains from Investment Securities value was $13.4 million (recorded in 2021), while the average stood at $63.0 million.
  • As far as peak fluctuations go, Intuitive Surgical's Gains from Investment Securities crashed by 3759.4% in 2022, and later skyrocketed by 7831.33% in 2023.
  • Intuitive Surgical's Gains from Investment Securities (Quarter) stood at $10.4 million in 2021, then crashed by 33.65% to $6.9 million in 2022, then soared by 34.78% to $9.3 million in 2023, then soared by 34.41% to $12.5 million in 2024, then increased by 4.8% to $13.1 million in 2025.
  • Its Gains from Investment Securities stands at $13.1 million for Q4 2025, versus $19.7 million for Q3 2025 and $16.2 million for Q2 2025.